Furthermore, human tissue analysis revealed lower nuclear NRF2 expression in IPMN compared with PanIN and PDA, suggesting distinct regulatory mechanisms across pancreatic precursor lesions. The gene discussed is NFE2L2; the disease is Patent ductus arteriosus.